Rentschler Expands Single-Use Manufacturing Capacities
News Jun 07, 2014
Rentschler Biotechnologie GmbH has announced the addition of a 2,000 L single-use bioreactor to its facility in Laupheim. The expansion is anticipated to be fully operational end of the first quarter of 2015.
The new 2,000 L single-use bioreactor will supplement two existing 1,000 L single-use bioreactors already in operation and will double the total single-use production capacity.
“We see an increasing need for production capacity in the mid-scale. The expansion will allow us to match the growing demands of our clients for all clinical phases. The addition of the 2,000 L single-use bioreactor will increase our flexibility to serve the market with either stainless steel or single-use technology as the client requires”, explains Frank Ternes, Chief Business Officer at Rentschler.
In 2012, Rentschler has received the “Facility of the Year Award” for its flexible, multi-product 1,000 L manufacturing facility designed to minimize manufacturing costs and product cycle times. Single-use equipment reduces contamination risks and permits a faster product turnaround with a shortened setup time and hence increases the capacity utilization.
The facility features a flexible space concept comprising four independent, connectable, multi-purpose clean room suites. The new 2,000 L single-use bioreactor seamlessly integrates in this proven facility concept.
Rentschler is one of the first CMOs having established a fully disposable process concept and already has more than three years of experience with this system.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Nanoparticle Delivery of Curcumin Induces Tumor Cell DeathNews
Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cellsREAD MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Comments | 0 ADD COMMENT
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017